| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
21 Adenosine-producing B cells in patients with head and neck cancer
|
Huber, U.
|
|
2015
|
51 |
5 |
p. e34-
1 p.
|
artikel
|
| 2 |
Adjuvant treatment for head and neck cancer in solid organ transplant recipients
|
Rabinovics, Naomi
|
|
2015
|
51 |
5 |
p. e23-e25
nvt p.
|
artikel
|
| 3 |
A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma
|
Anderson, Caroline Rachael
|
|
2015
|
51 |
5 |
p. 464-469
6 p.
|
artikel
|
| 4 |
36 A new anticancer drug in sinonasal carcinoma targeting the NFkB pathway
|
García-Inclán, C.
|
|
2015
|
51 |
5 |
p. e38-
1 p.
|
artikel
|
| 5 |
Assessment and measurement of head and neck lymphedema: State-of-the-science and future directions
|
Deng, Jie
|
|
2015
|
51 |
5 |
p. 431-437
7 p.
|
artikel
|
| 6 |
Can meta-analysis be replaced by best-evidence synthesis in oral oncology systematic review?
|
Yang, Wenbin
|
|
2015
|
51 |
5 |
p. e21-
1 p.
|
artikel
|
| 7 |
6 CD98 identifies a clinically relevant subpopulation of head and neck squamous cell carcinoma cells with stem cell properties
|
Martens-de Kemp, S.R.
|
|
2015
|
51 |
5 |
p. e29-
1 p.
|
artikel
|
| 8 |
42 CD56-positive lymphocyte infiltration in correlation with outcome and human papilloma virus association of oropharyngeal squamous cell carcinoma
|
Wagner, S.
|
|
2015
|
51 |
5 |
p. e40-
1 p.
|
artikel
|
| 9 |
33 Cetuximab paying toll to improve its therapeutic efficacy – Improving cetuximab-mediated head and neck cancer treatment via co-activation of Fc-receptors and toll-like receptors
|
Bakema, J.
|
|
2015
|
51 |
5 |
p. e37-
1 p.
|
artikel
|
| 10 |
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma
|
Raju, Sharat C.
|
|
2015
|
51 |
5 |
p. 470-475
6 p.
|
artikel
|
| 11 |
Comment on “Tumour thickness as a predictor of nodal metastases in oral cancer: Comparison between tongue and floor of mouth subsites” by Balasubramanian D et al.
|
Swain, Niharika
|
|
2015
|
51 |
5 |
p. e26-
1 p.
|
artikel
|
| 12 |
27 Comparison of the effects of tumor cells, fibroblasts and TGF- β 1 on growth, migration and epithelial-to-mesenchymal transdifferentiation (EMT) of oral squamous cell carcinoma
|
Metzler, V.
|
|
2015
|
51 |
5 |
p. e36-
1 p.
|
artikel
|
| 13 |
24 Cross-talk of tumor cells with mesenchymal stromal cells enhances tumor progression in head and neck cancer
|
Dissmann, P.
|
|
2015
|
51 |
5 |
p. e35-
1 p.
|
artikel
|
| 14 |
25 Different subsets of carcinoma-associated fibroblasts promote oral carcinoma cell invasion by distinct mechanisms
|
Costea, D.E.
|
|
2015
|
51 |
5 |
p. e35-
1 p.
|
artikel
|
| 15 |
29 Direct observation of living laryngeal carcinoma cells during invasion of healthy cell formation
|
Zenner, H.-P.
|
|
2015
|
51 |
5 |
p. e36-
1 p.
|
artikel
|
| 16 |
Editorial Board/Aims & Scope
|
|
|
2015
|
51 |
5 |
p. i-
1 p.
|
artikel
|
| 17 |
19 Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells
|
Mrizak, D.
|
|
2015
|
51 |
5 |
p. e33-
1 p.
|
artikel
|
| 18 |
Effect of previous history of cancer on survival of patients with a second cancer of the head and neck
|
Jégu, Jérémie
|
|
2015
|
51 |
5 |
p. 457-463
7 p.
|
artikel
|
| 19 |
Effects of metformin on head and neck cancer: A systematic review
|
Rêgo, Daniela Fortunato
|
|
2015
|
51 |
5 |
p. 416-422
7 p.
|
artikel
|
| 20 |
2 Effects of sorafenib treatment on HNSCC cells in combination with cisplatin based-chemoradiation
|
Möckelmann, N.
|
|
2015
|
51 |
5 |
p. e27-e28
nvt p.
|
artikel
|
| 21 |
ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
|
Xuelei, Ma
|
|
2015
|
51 |
5 |
p. 483-492
10 p.
|
artikel
|
| 22 |
28 Expression of integrin α -11 by carcinoma associated fibroblasts modulates oral squamous cell carcinoma behavior
|
Parajuli, H.
|
|
2015
|
51 |
5 |
p. e36-
1 p.
|
artikel
|
| 23 |
48 Expression pattern and significance of homeodomain only protein (HOPX) in head and neck cancer
|
Gokulan, R.C.
|
|
2015
|
51 |
5 |
p. e41-
1 p.
|
artikel
|
| 24 |
18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients
|
Meeuwis, Jasmijn
|
|
2015
|
51 |
5 |
p. 536-540
5 p.
|
artikel
|
| 25 |
15 Genetic biomarkers in head and neck squamous cell carcinoma
|
Golusinski, P.
|
|
2015
|
51 |
5 |
p. e32-
1 p.
|
artikel
|
| 26 |
High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer
|
Sinha, Parul
|
|
2015
|
51 |
5 |
p. 514-520
7 p.
|
artikel
|
| 27 |
3 Identification of anti-apoptotic caspase 9b in head and neck squamous cell carcinoma
|
Maushagen, R.
|
|
2015
|
51 |
5 |
p. e28-
1 p.
|
artikel
|
| 28 |
49 Identification of kallikrein-related peptidase 6 in primary mucosal malignant melanoma of the head and neck
|
Thierauf, J.
|
|
2015
|
51 |
5 |
p. e41-e42
nvt p.
|
artikel
|
| 29 |
20 IFN γ -induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
|
Concha-Benavente, F.
|
|
2015
|
51 |
5 |
p. e33-
1 p.
|
artikel
|
| 30 |
38 Immune evasion of HPV-associated HNSCC
|
Reuschenbach, M.
|
|
2015
|
51 |
5 |
p. e39-
1 p.
|
artikel
|
| 31 |
4 Immune response evaluation to curative conventional therapy – The IRECT trial
|
Laban, S.
|
|
2015
|
51 |
5 |
p. e28-e29
nvt p.
|
artikel
|
| 32 |
17 Impact of polymorphonuclear cells (PMN) in head and neck cancer progression: A mouse model to investigate time dependent functions of PMN
|
Moses, K.
|
|
2015
|
51 |
5 |
p. e32-
1 p.
|
artikel
|
| 33 |
46 Indoleamine 2,3-dioxygenase and cancerous inhibitor of pp2A expression and inflammation in lingual hyperplasia and tongue cancer
|
Lehtinen, M.
|
|
2015
|
51 |
5 |
p. e40-e41
nvt p.
|
artikel
|
| 34 |
50 Influence of microRNA expression profiles on the efficacy of radiochemotherapy in locally advanced head and neck squamous cell carcinoma
|
Heß, A.-K.
|
|
2015
|
51 |
5 |
p. e42-
1 p.
|
artikel
|
| 35 |
12 Invited lecture: High-throughput functional genomics – An emerging field in head and neck cancer research
|
Brakenhoff, R.H.
|
|
2015
|
51 |
5 |
p. e31-
1 p.
|
artikel
|
| 36 |
37 Invited lecture: Mechanisms of tumor clearance in HPV-associated HNSCC
|
Lee, J.
|
|
2015
|
51 |
5 |
p. e38-e39
nvt p.
|
artikel
|
| 37 |
23 Invited lecture: Tumor–stroma interactions promote operational flexibility in cancer progression
|
De Wever, O.
|
|
2015
|
51 |
5 |
p. e34-e35
nvt p.
|
artikel
|
| 38 |
41 Is HPV infection the first genetic hit in head and neck cancer?
|
Rietbergen, M.M.
|
|
2015
|
51 |
5 |
p. e39-e40
nvt p.
|
artikel
|
| 39 |
10 Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients
|
Schrader, C.
|
|
2015
|
51 |
5 |
p. e30-
1 p.
|
artikel
|
| 40 |
9 Matrix remodeling in head and neck squamous cell carcinomais
|
Dudas, J.
|
|
2015
|
51 |
5 |
p. e30-
1 p.
|
artikel
|
| 41 |
31 MCPyV and the immune system: Target and modulator
|
Becker, J.C.
|
|
2015
|
51 |
5 |
p. e36-e37
nvt p.
|
artikel
|
| 42 |
11 Mechanism of perineural invasion in head and neck cancer
|
Kim, S.W.
|
|
2015
|
51 |
5 |
p. e30-e31
nvt p.
|
artikel
|
| 43 |
Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN)
|
Price, Katharine A.R.
|
|
2015
|
51 |
5 |
p. 399-408
10 p.
|
artikel
|
| 44 |
Meta-analysis on the association between toothbrushing and head and neck cancer
|
Zeng, Xian-Tao
|
|
2015
|
51 |
5 |
p. 446-451
6 p.
|
artikel
|
| 45 |
39 Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
|
Pogorzelski, M.
|
|
2015
|
51 |
5 |
p. e39-
1 p.
|
artikel
|
| 46 |
Mouth opening in patients irradiated for head and neck cancer: A prospective repeated measures study
|
Kamstra, J.I.
|
|
2015
|
51 |
5 |
p. 548-555
8 p.
|
artikel
|
| 47 |
14 Next generation sequencing (NGS) approach to identify genetic alterations in head and neck squamous cell carcinoma
|
Niehr, F.
|
|
2015
|
51 |
5 |
p. e31-e32
nvt p.
|
artikel
|
| 48 |
13 No molecular evidence for the role of the genetic background of the host in explaining lymph node metastasis in head and neck cancer
|
Mes, S.
|
|
2015
|
51 |
5 |
p. e31-
1 p.
|
artikel
|
| 49 |
Orthotopic non-metastatic and metastatic oral cancer mouse models
|
Bais, Manish V.
|
|
2015
|
51 |
5 |
p. 476-482
7 p.
|
artikel
|
| 50 |
P40 Aberrant epigenetic and genetic TP53 novel translational expression of codon 240 (Ser240Thr) – Association with squamous cell carcinoma of head and neck
|
Saleem, S.
|
|
2015
|
51 |
5 |
p. e55-
1 p.
|
artikel
|
| 51 |
P34 Angiogenesis at the primary tumor site is a potential driver of lymphatic metastasis in squamous cell carcinoma of the larynx
|
Schlüter, A.
|
|
2015
|
51 |
5 |
p. e53-
1 p.
|
artikel
|
| 52 |
P39 Behavior of circulating tumor cells in patients with locally advanced squamous cell carcinoma of the head and neck during therapy: A prospective study
|
Inhestern, J.
|
|
2015
|
51 |
5 |
p. e54-e55
nvt p.
|
artikel
|
| 53 |
P24 Biomaterial-based tissue-like constructs for assessing effects of vismodegib on soft and hard tissue
|
Booms, P.
|
|
2015
|
51 |
5 |
p. e49-e50
nvt p.
|
artikel
|
| 54 |
P37 BTK inhibitor Ibrutinib regulates the TLR3 induced IL-1ß expression in HNSCC
|
Lanka, A.
|
|
2015
|
51 |
5 |
p. e54-
1 p.
|
artikel
|
| 55 |
P22 Cancer stem cell marker aldehyde dehydrogenase 1 expression in oral squamous cell carcinoma – An immunohistochemistry study
|
El-Rouby, D.
|
|
2015
|
51 |
5 |
p. e49-
1 p.
|
artikel
|
| 56 |
P13 Can the epidermal growth factor receptor inhibitor cetuximab make a difference in locally advanced head and neck cancers outcomes?
|
Al-Saleh, K.
|
|
2015
|
51 |
5 |
p. e46-
1 p.
|
artikel
|
| 57 |
P17 Clinical features and prognostic factors in patients with head and neck cancer – Results from a multicentric study
|
Cadoni, G.
|
|
2015
|
51 |
5 |
p. e47-e48
nvt p.
|
artikel
|
| 58 |
P18 Clinical management of intestinal-type sinonasal adenocarcinoma: A monoinstitutional experience of 165 cases
|
Costales, M.
|
|
2015
|
51 |
5 |
p. e48-
1 p.
|
artikel
|
| 59 |
P2 Correlation of macrophage polarization and Gal-3 expressing cells in oral squamous cell carcinomas with the occurrence of lymph node metastases
|
Weber, M.
|
|
2015
|
51 |
5 |
p. e42-e43
nvt p.
|
artikel
|
| 60 |
P41 Effectiveness of selected HDAC inhibitors on head and neck squamous cell carcinoma cell lines
|
Enzenhofer, E.
|
|
2015
|
51 |
5 |
p. e55-
1 p.
|
artikel
|
| 61 |
P25 Effect of bioactive compounds of zingiber officinale roscoe on head and neck tumor cell lines
|
Kotowski, U.
|
|
2015
|
51 |
5 |
p. e50-
1 p.
|
artikel
|
| 62 |
P19 Evidence for histological lesions precursor to intestinal-type sinonasal adenocarcinoma
|
Vivanco, B.
|
|
2015
|
51 |
5 |
p. e48-
1 p.
|
artikel
|
| 63 |
P4 Exploring the contribution of the microenvironment of HPV-induced and non-HPV induced squamous cell carcinoma of head and neck
|
Cioni, B.
|
|
2015
|
51 |
5 |
p. e43-
1 p.
|
artikel
|
| 64 |
P38 Galanin receptors are correlated with different signaling pathways in human head and neck cancer
|
Medeiros, M.
|
|
2015
|
51 |
5 |
p. e54-
1 p.
|
artikel
|
| 65 |
P35 Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals a subgroup of patients with favourable clinical outcome
|
López-Hernández, A.
|
|
2015
|
51 |
5 |
p. e53-e54
nvt p.
|
artikel
|
| 66 |
P33 HPV16-dependent promoter methylation in HNSCC
|
Boecker, A.J.
|
|
2015
|
51 |
5 |
p. e53-
1 p.
|
artikel
|
| 67 |
P28 HPV/p16 positivity is associated with improved survival in oropharyngeal cancer patients treated with postoperative radiotherapy
|
Heiduschka, G.
|
|
2015
|
51 |
5 |
p. e51-
1 p.
|
artikel
|
| 68 |
P21 Immunohistochemical analysis of clinical and pathological relevance of LOXL4- and survivin expressions in oropharyngeal carcinomas
|
Diercks, I.
|
|
2015
|
51 |
5 |
p. e49-
1 p.
|
artikel
|
| 69 |
P11 Induction of immunomodulatory cell death by synthetic RNA mimetics
|
Klein, J.
|
|
2015
|
51 |
5 |
p. e45-e46
nvt p.
|
artikel
|
| 70 |
P10 Interactions of fibroblasts derived from irradiated subcutaneous connective tissue with HNSCC
|
Gehrke, T.
|
|
2015
|
51 |
5 |
p. e45-
1 p.
|
artikel
|
| 71 |
P7 Investigating the role of the novel cytokine IL-35 in the regulation of anti-tumour immunity against head and neck cancer
|
Al-Hussaini, A.
|
|
2015
|
51 |
5 |
p. e44-e45
nvt p.
|
artikel
|
| 72 |
P23 Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer – A case-control analysis
|
Becker, C.
|
|
2015
|
51 |
5 |
p. e49-
1 p.
|
artikel
|
| 73 |
45 Polo-like-kinase-1 as a potential therapeutic target in merkel cell carcinoma
|
Kadletz, L.
|
|
2015
|
51 |
5 |
p. e40-
1 p.
|
artikel
|
| 74 |
P3 Peripheral tolerance in regional lymph nodes is associated with parameters of malignancy in oral squamous cell carcinomas
|
Wehrhan, F.
|
|
2015
|
51 |
5 |
p. e43-
1 p.
|
artikel
|
| 75 |
P31 Prevalence of human papillomavirus in laryngeal and hypopharyngeal squamous cell carcinomas
|
Hermsen, M.
|
|
2015
|
51 |
5 |
p. e52-
1 p.
|
artikel
|
| 76 |
P20 Prognostic and predictive biomarkers related to p53 pathway and clinical outcome in platinum-treated locally advanced head and neck cancer – A revision after >10years of a monocentric patient’s population
|
Lo Nigro, C.
|
|
2015
|
51 |
5 |
p. e48-e49
nvt p.
|
artikel
|
| 77 |
P15 Prognostic markers in early glottic cancer
|
Haymerle, G.
|
|
2015
|
51 |
5 |
p. e47-
1 p.
|
artikel
|
| 78 |
P16 Prognostic value of ABO blood group in southern chinese patients with laryngeal cancer
|
Jin, T.
|
|
2015
|
51 |
5 |
p. e47-
1 p.
|
artikel
|
| 79 |
P32 Prospective study on human papillomavirus significance in oral dysplasias in association with clinical parameters and P16INK4a expression
|
Prigge, E.-S.
|
|
2015
|
51 |
5 |
p. e52-e53
nvt p.
|
artikel
|
| 80 |
P1 Quantification of the inflammatory tumor microenvironment in carcinomas of the larynx
|
Kanaan, O.
|
|
2015
|
51 |
5 |
p. e42-
1 p.
|
artikel
|
| 81 |
Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer
|
Bahig, Houda
|
|
2015
|
51 |
5 |
p. 521-528
8 p.
|
artikel
|
| 82 |
P5 Retrospective analysis on the expression of CD70 in squamous cell carcinoma of the head and neck (HNSCC) and its relation to patient outcome
|
De Meulenaere, A.
|
|
2015
|
51 |
5 |
p. e43-e44
nvt p.
|
artikel
|
| 83 |
22 Prognostic impact of tumor associated macrophages and tumor infiltrating lymphocytes in head and neck cancer treated with primary chemoradiotherapy
|
Balermpas, P.
|
|
2015
|
51 |
5 |
p. e34-
1 p.
|
artikel
|
| 84 |
47 Prognostic markers in stage 1 oral cavity squamous cell carcinoma
|
Dunkel, J.
|
|
2015
|
51 |
5 |
p. e41-
1 p.
|
artikel
|
| 85 |
P14 Saliva based biomarkers in head and neck cancer
|
Kaur, J.
|
|
2015
|
51 |
5 |
p. e47-
1 p.
|
artikel
|
| 86 |
P30 Stabilization of hypoxia-inducible factor-1 α (HIF1A) – Basis of carcinogenesis and induction of the Warburg effect in HPV-associated OSCC?
|
Knuth, J.
|
|
2015
|
51 |
5 |
p. e52-
1 p.
|
artikel
|
| 87 |
P27 The combined use of anti-EGFr and anti-JAK/STAT-3 agents as radiosensitizers in HPV negative and positive head and neck cancer cell lines
|
Bonner, J.A.
|
|
2015
|
51 |
5 |
p. e50-e51
nvt p.
|
artikel
|
| 88 |
P6 The effect of soluble factors derived from the head and neck tumour microenvironment on the proliferation of isolated immune cell populations
|
Smith, J.
|
|
2015
|
51 |
5 |
p. e44-
1 p.
|
artikel
|
| 89 |
P9 The interaction of hMSC and HNSCC under hypoxic and normoxic circumstances in vitro
|
Scherzad, A.
|
|
2015
|
51 |
5 |
p. e45-
1 p.
|
artikel
|
| 90 |
P36 The role of EGFR pathway activation in sinonasal carcinoma
|
López, F.
|
|
2015
|
51 |
5 |
p. e54-
1 p.
|
artikel
|
| 91 |
P29 The role of HPV in cervical lymph node metastases from squamous cell carcinoma
|
Schroeder, L.
|
|
2015
|
51 |
5 |
p. e51-e52
nvt p.
|
artikel
|
| 92 |
P26 The utility of coupler devices for arterial anastomosis in free tissue transfer
|
Uenal, N.
|
|
2015
|
51 |
5 |
p. e50-
1 p.
|
artikel
|
| 93 |
P12 TLR8 agonist VTX-2337 sensitizes head and neck cancer cells to cetuximab
|
Lei, Y.
|
|
2015
|
51 |
5 |
p. e46-
1 p.
|
artikel
|
| 94 |
P8 Tumor-associated B cells in head and neck squamous cell carcinoma (HNSCC)
|
Lechner, A.
|
|
2015
|
51 |
5 |
p. e45-
1 p.
|
artikel
|
| 95 |
Re: Haddad et al. Barriers to clinical trial recruitment in head and neck cancer
|
Main, B.G.
|
|
2015
|
51 |
5 |
p. e22-
1 p.
|
artikel
|
| 96 |
Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET–CT
|
Schouten, Charlotte S.
|
|
2015
|
51 |
5 |
p. 541-547
7 p.
|
artikel
|
| 97 |
Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation
|
Shah, Ketan
|
|
2015
|
51 |
5 |
p. 529-535
7 p.
|
artikel
|
| 98 |
Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group
|
Osazuwa-Peters, Nosayaba
|
|
2015
|
51 |
5 |
p. 452-456
5 p.
|
artikel
|
| 99 |
Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases
|
Chen, Tseng-Cheng
|
|
2015
|
51 |
5 |
p. 493-499
7 p.
|
artikel
|
| 100 |
32 STAT1 regulates HLA class I upregulation and immunogenicity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients
|
Srivastava, R.M.
|
|
2015
|
51 |
5 |
p. e37-
1 p.
|
artikel
|
| 101 |
18 Surface binding followed by Ca2+ influx results in selective activation of human regulatory T cells (Treg) by tumor-derived exosomes (TEX)
|
Muller, L.
|
|
2015
|
51 |
5 |
p. e33-
1 p.
|
artikel
|
| 102 |
Survival benefit for adjuvant radiation therapy in minor salivary gland cancers
|
Zeidan, Youssef H.
|
|
2015
|
51 |
5 |
p. 438-445
8 p.
|
artikel
|
| 103 |
Targeting angiogenesis in head and neck cancer
|
Vassilakopoulou, Maria
|
|
2015
|
51 |
5 |
p. 409-415
7 p.
|
artikel
|
| 104 |
Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma
|
Boscolo-Rizzo, Paolo
|
|
2015
|
51 |
5 |
p. 500-507
8 p.
|
artikel
|
| 105 |
26 TGF-beta induced interaction of human MSC coculture with HNSCC cell line PCI-13
|
Godek, F.
|
|
2015
|
51 |
5 |
p. e35-e36
nvt p.
|
artikel
|
| 106 |
The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas
|
Martinez-Useros, Javier
|
|
2015
|
51 |
5 |
p. 423-430
8 p.
|
artikel
|
| 107 |
8 Therapy resistance in HNSCC – Enhanced levels of the cytoprotective protein survivin is mediated by down-regulation of microRNA-542-3p
|
Gößwein, D.
|
|
2015
|
51 |
5 |
p. e29-e30
nvt p.
|
artikel
|
| 108 |
35 The role of toll-like receptor (TLR) agonists in combinational immunotherapy for head and neck cancer
|
Kansy, B.
|
|
2015
|
51 |
5 |
p. e38-
1 p.
|
artikel
|
| 109 |
7 Tumor budding as a prognostic marker in head and neck cancer – A systematic review
|
Almangush, A.
|
|
2015
|
51 |
5 |
p. e29-
1 p.
|
artikel
|
| 110 |
34 Tumoricidal immune response to papillomavirus-associated head and neck cancer in rabbits after intraperitoneal oxidative stress
|
Mandic, R.
|
|
2015
|
51 |
5 |
p. e37-e38
nvt p.
|
artikel
|
| 111 |
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer
|
Bernstein, Jonathan M.
|
|
2015
|
51 |
5 |
p. 508-513
6 p.
|
artikel
|
Tijdschrift beschrijving